Pharmaceutical Technology

MARCH 14, 2023

The company is involved in designing and manufacturing nanoparticles that safely enhance radiation therapy's efficacy in cancer treatment. The company’s lead asset is NBTXR3, which is based on hafnium oxide nanoparticle that is designed to destroy tumors when activated by radiotherapy.

Leads 72

Leads Biopharma Pharmaceutical Manufacturing 72

PM360

AUGUST 9, 2022

Biopharma blockbusters in the last 10 years show a disturbing trend. As a top 10 biopharma company leader shared with us, “Real blockbusters are gone. For biopharma, success in this space will require integrated models that are significantly different than what has been used with historic medicines. In oncology, it’s 47% less.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

pharmaphorum

DECEMBER 18, 2022

Uniquely positioned, traditional patient access hubs promise to simplify the process of getting patients started on therapy and offer to provide HCPs with much-needed assistance in navigating payer requirements leading up to therapy starts. However, the cumbersome hub workflow overshadows the purported gains in productivity.

Biopharma 87

Biopharma Patients Prescription Medical 87

Pharmaceutical Technology

MAY 24, 2023

Amgen develops, manufactures, and markets innovative human medicines to treat patients suffering from serious diseases. Whilst Abliva and Ambrx Biopharma stand in second and third positions, respectively. Merck 42 Unlock company profile C. Menarini Industrie Farmaceutiche Riunite.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Pharmacology 52

Pharmaceutical Technology

MAY 8, 2023

Hoffmann-La Roche is the leading patent filer in monoclonal antibody conjugates for cancer treatment. Kadcyla, one of the two marketed drugs, is manufactured by Roche. By means of geographic reach, Astellas Pharma holds the top position, while TRON and Eisai stand in second and third positions, respectively.

Leads 52

Leads Biopharma Pharmaceutical Pharma 52

European Pharmaceutical Review

OCTOBER 4, 2023

Eli Lilly and Company has agreed to acquire the radiopharmaceutical firm POINT Biopharma Global for $1.4 POINT’s lead programmes are currently in late-stage development. The company’s other lead radiopharmaceutical candidate is PNT2003, or lutetium-177 Octreotate (177Lu-DOTATATE). The post Lilly agrees $1.4

Biopharma 97

Biopharma Medicine Leads Manufacturing 97

pharmaphorum

AUGUST 4, 2022

This is due to the specialist nature of roles and the growth and diversification of biopharma, which requires an increasingly sophisticated and skilled workforce. Furthermore, by simulating real-life scenarios, AR offers the chance for staff in the pharma industry to practice complex operations without the associated risks.

Recruitment 91

Recruitment Pharma Training Pharmaceutical manufacturing 91

European Pharmaceutical Review

SEPTEMBER 26, 2022

AbbVie , an international R&D biopharmaceutical enterprise has celebrated its 20th anniversary by investing in extensive renovations at its manufacturing site in Cork, Ireland. The €60 million expansion will open 70 new jobs in sterile manufacturing, quality control and engineering in 2025. AbbVie announces Michael Severino, M.D.

Manufacturing 81

Manufacturing Pharmaceutical manufacturing Biopharma Engineering 81

PM360

DECEMBER 20, 2023

With 2024 on the horizon, many in the biopharma space are taking stock of 2023 and what the current environment means for their potential success next year. This may best be achieved by large pharma companies, with their combined $200bn annual R&D budget, compared to smaller companies that are relying on external investment.

Biopharma 111

Biopharma Pharma Marketing Management 111

Clarivate

MAY 14, 2024

While initially developed to help regulate blood sugar levels, they have also been found to promote appetite suppression, leading to weight loss in patients. What’s leading to the boom in development of semaglutide biosimilars? Per recent Clarivate estimates, the therapeutic market for these drugs is valued at approximately $1.7

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

Pharmaceutical Technology

JUNE 29, 2022

For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. Meanwhile, the pharma industry is undergoing somewhat of a transformation itself. The impact could be huge for the biopharma industry.

Specialization 118

Specialization Biopharma B2B Sales Manufacturing 118

PM360

SEPTEMBER 28, 2022

At Roche at the time, his job was to lead a task force which was given the objective of planning a strategy to preserve and protect the companies billion-dollar originator biologics franchises as well as build a plan which would counter the introduction and use of biosimilars. Now, as the President of Accord BioPharma , the U.S.

Competition 98

Competition Marketing Biopharma Manufacturing 98

Pharma Pathway

DECEMBER 31, 2022

Company Profile: INTAS Pharmaceutical is a leading, vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. Desired Candidate Profile: Candidate should have experience in Biopharma/ Biotech Industry. Job Description. Involved in Analytical method Validation.

Pharmaceutical 52

Pharmaceutical Biopharma Manufacturing Leads 52

PM360

OCTOBER 3, 2023

PRODUCT LAUNCH OF THE YEAR NEXTSTELLIS (Mayne Pharma and EVERSANA INTOUCH) RELAUNCH/REVITALIZATION OF THE YEAR VRAYLAR (AbbVie Inc. Diversity/Multicultural: Anna Czene, Vice President, Corporate Communications & DEI Lead, CareDx, Inc. and Publicis NY) BRAND CHAMPION AWARD WINNERS Autoimmune/Rheumatology: Katrina Sergeev Gary, Sr.

Education 122

Education Marketing Media Management 122

Pharmaceutical Technology

MARCH 1, 2023

Venture financing for early-stage innovator drugs for biotech companies based in the Asia-Pacific (APAC) region between 2018 to 2022 received three times less funding, at $23bn, than their US counterparts, at $72bn, according to GlobalData’s Pharma Intelligence Centre Deals Database.

Pharma 72

Pharma Biopharma Marketing Pharmaceutical 72

Pharmaceutical Technology

NOVEMBER 4, 2022

As visibility diminishes, mismanagement of the supply chain can not only lead to revenue and reputational damage for manufacturers but more importantly, loss of life for patients. The expertise in procurement for new projects is a definite advantage with choosing a CMO like Baxter BioPharma Solutions.

Biopharma 52

Biopharma Manufacturing Media Pharmaceutical 52

Clarivate

MARCH 14, 2024

1] To mitigate the potential presence of nitrosamine impurities in pharmaceuticals, manufacturers are now facing impending regulatory requirements in various markets – in the European Union, for example, they were obligated to submit reformulation strategies and mitigation plans in late 2022. [2].

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

PM360

DECEMBER 14, 2023

Moderna Joins CEPI Pandemic Preparedness Mission After making its debut in the pharma market during the COVID-19 pandemic, Moderna is preparing for the next pandemic. The pharma company has joined the Coalition for Epidemic Preparedness Innovations (CEPI) in a partnership that aims to shorten vaccine development timelines down to 100 days.

Physicians 52

Physicians Pharma Medical Patients 52

European Pharmaceutical Review

APRIL 30, 2024

What are the top three trends that you are seeing in the biopharma manufacturing space? This resulted in not only a mismatch in the required manufacturing scale but also a significant over capacity as well. Let’s talk about continuous biopharma manufacturing. What are the main challenges in this area in particular?

Manufacturing 78

Manufacturing Food and Drug Administration Biopharma Marketing 78

Pharmaceutical Technology

APRIL 4, 2023

While Scorpion will lead the development of STX-721, Pierre Fabre will handle STX-241. According to GlobalData’s Pharma Intelligence Centre, Tagrisso is forecasted to have global sales of $8.19 The biopharma aims to start the study as soon as the IND is cleared by the FDA. Up to 12.5% billion in 2029.

Food and Drug Administration 52

Food and Drug Administration Biopharma FDA Pharmaceutical 52

pharmaphorum

SEPTEMBER 30, 2022

New manufacturers, such as EQRx, have been vocal in their desire to bring new PD-1/PD-L1 checkpoint inhibitors (e.g. Perhaps more interestingly, similar signals have also emerged from traditional biopharma heavyweights, such as Novartis and Lilly, which one would typically associate with more conservative approaches to pricing.

Consulting 82

Consulting Marketing Pharma Manufacturing 82

PM360

AUGUST 24, 2023

PM360 , a leading life sciences marketing industry trade publication, established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. Braun Medical, Inc.

Marketing 52

Marketing Education Media Healthcare 52

PM360

OCTOBER 5, 2023

In total, PM360 , a leading life sciences marketing industry trade publication, recognized 73 winners across eight overall categories: Companies of the Year, CEOs of the Year, Products of the Year, Marketer of the Year, Marketing Team of the Year, Lifetime Achievement, Brand Champions, and Initiatives.

Education 52

Education Marketing Media Biopharma 52

European Pharmaceutical Review

NOVEMBER 1, 2022

Putting pandemic-related factors aside, a significant portion of the heightened demand for CRO/CDMO services has been driven by VC-backed pharma and biopharma companies. Significantly, Scanlan states that the current industry-predicted growth rates of 7.2 percent 1 for CROs and 8.5 1 Source: Piper Sandler.

Pharma 52

Pharma Biopharma Marketing Networking 52

eMediWrite

JUNE 6, 2022

However, if you asked the same people who make such medicines, considerably fewer people would be able to respond with the right manufacturers’ company name. This, combined with the rise of technology in pharma, raises the question of whether it’s time for pharma businesses to reconsider their corporate branding approach.

Pharmaceutical 52

Pharmaceutical Pharma Marketing Medicine 52

Clarivate

OCTOBER 25, 2023

What the addition of Part B may bring With the expansion of price negotiations to include Part B drugs in 2028 , Medicare reimbursement may become challenging for additional manufacturers. B&B allows larger practices to negotiate for better reimbursement rates from commercial payers and larger manufacturer discounts/rebates.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Pharma Marketing Network

JANUARY 12, 2023

She has been responsible for overseeing the full lifecycle of product portfolios, from discovery and development to commercialization and manufacturing. The Kite team now includes more than 4,000 employees dedicated to all aspects of cell therapy from business development and R&D to commercial and manufacturing.

Healthcare 52

Healthcare Healthcare Networking Manufacturing 52

European Pharmaceutical Review

DECEMBER 19, 2022

1 However, as most biosimilars are developed by means of a complex biotechnological process in living organisms, this inevitably leads to differences between the biosimilar and the reference product. Marie Manley leads Sidley’s Life Sciences team in London and is a distinguished thought leader and adviser on EU and UK regulatory law.

Medicine 52

Medicine Biopharma Safety Food 52

European Pharmaceutical Review

AUGUST 24, 2023

This strategy shift did not occur overnight, but evolved in response to the changing biopharma landscape. Even among the leaders of the biopharma sector, few companies have a significant presence across these platforms, Baral highlighted. Venture funding in 2022 came in at about $13.7 billion, down from the high of 2021.

Biopharma 80

Biopharma Pharmaceutical Pharma Medical 80

PM360

SEPTEMBER 15, 2022

Quantitative survey results can often lead to a false sense of security around pre-selected response options, therefore missing critical contextual information that helps someone truly understand the patient’s perspective. med info or case managers) for consumers to contact the manufacturer and ask questions. Rachel Ballinger.

Patients 98

Patients Healthcare Healthcare Marketing 98

European Pharmaceutical Review

NOVEMBER 15, 2023

Analytical methods for PAT applications in biopharma Authors of the paper wrote that overall, many established off-line analytical methods such as mass spectrometry, are not often considered for PAT applications in biopharmaceutical processes. emphasised.

Biopharma 73

Biopharma Manufacturing Pharma Leads 73

Pharmaceutical Technology

MAY 24, 2023

Every major pharma company is now involved in CGT development which has resulted in the approval of 28 therapies by the FDA thereby making CGT no longer a niche category of therapies. This major difference leads to very different requirements and processes for the clinical trial supply chain, which are summarized below.

Manufacturing 98

Manufacturing Transportation Specialization Patients 98

Pharmaceutical Technology

AUGUST 26, 2008

As understanding of biological systems has forged ahead, pharmaceutical companies have made increasing use of biotechnology in discovering and manufacturing new medicines. It was once derided as the stuff of science fiction, but in recent years, biotechnology has emerged as an important growth area in pharmaceuticals.

Manufacturing 52

Manufacturing Pharmaceutical Biopharma Medicine 52

Clarivate

AUGUST 8, 2023

The biopharma industry is sweating the long-term implications and warning that it could mean less lifesaving drugs make it to patients going forward. The law was top-of-mind at this summer’s ASCO and BIO meetings, tentpole events in the biopharma conference calendar. R&D efficiency is more critical than ever.

Biopharma 52

Biopharma Pharma Prescription Manufacturing 52

Pharmaceutical Technology

APRIL 24, 2023

Biologics are costly to produce and sell, and the more recent modalities, such as cell and gene therapies, can be difficult to manufacture. With new drugs on the market, companies are now looking for ways to manufacture recently approved biologics, and countries are racing to claim their corner – or maintain their decades-old market share.

Manufacturing 52

Manufacturing Food and Drug Administration Biopharma Sales 52

Pharmaceutical Technology

MARCH 24, 2023

GC Biopharma is also running a Phase III trial for its live-attenuated vaccine GC-3107A to replace BCG. Accounting for the time needed to complete the trial, publish results and manufacture the vaccine, if successful, market access to TB vaccines may be 10 years away.

Pharma 64

Pharma Side effects Marketing Biopharma 64

Pharmaceutical Technology

APRIL 27, 2023

The successful development and deployment of the mRNA-based COVID-19 vaccines has catalysed the biopharma industry and paved the way to expand this drug modality to new therapeutic areas. This makes the requirement to establish a reliable and robust manufacturing process with clear scalability and compliance goals a priority.

Manufacturing 52

Manufacturing Marketing Medicine Transportation 52